secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K/A
Filed at:   2021-11-23T23:59:59+00:00
Accession:  0001104659-21-143057
Event type: leadership
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience appoints Dr. Melissa Starovasnik to Compensation Committee
---------------------------------------------------------------------------

- Dr. Melissa Starovasnik was appointed to the Compensation Committee of the Board on November 17, 2021.
- She was originally elected as a Class I director effective August 5, 2021, as previously reported.
- The amendment solely adds this committee assignment; no other changes to prior disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465921143057/0001104659-21-143057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465921143057/tm2133571d2_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-143057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer